These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847 [TBL] [Abstract][Full Text] [Related]
5. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery. Asghar LF; Azeemuddin M; Jain V; Chandran S Drug Deliv; 2009 May; 16(4):205-13. PubMed ID: 19514981 [TBL] [Abstract][Full Text] [Related]
6. Per-oral controlled release dosage form of theophylline using soybean protein. Machida Y; Tokumura T; Nagai T Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of pulsatile drug delivery system using novel polymer. Tekade AR; Gattani SG Pharm Dev Technol; 2009; 14(4):380-7. PubMed ID: 19235549 [TBL] [Abstract][Full Text] [Related]
8. A novel controlled porosity osmotic pump system for sodium ferulate. He L; Gong T; Zhao D; Zhang ZR; Li L Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661 [TBL] [Abstract][Full Text] [Related]
9. A solid-state NMR method to determine domain sizes in multi-component polymer formulations. Schlagnitweit J; Tang M; Baias M; Richardson S; Schantz S; Emsley L J Magn Reson; 2015 Dec; 261():43-8. PubMed ID: 26529201 [TBL] [Abstract][Full Text] [Related]
10. [Formal requirements and a cultural approach to the control of slow-release dosage forms]. Ciranni Signoretti E Boll Chim Farm; 1989 Jun; 128(6):199-201. PubMed ID: 2619987 [TBL] [Abstract][Full Text] [Related]
11. [Effect of euddragit and ethylcellulose coatings. A short review of pH and diffusion controlled drug delivery]. Bauer KH Med Klin (Munich); 1999 Feb; 94 Suppl 1():12-6. PubMed ID: 10194942 [TBL] [Abstract][Full Text] [Related]
13. Controlled release of tripelennamine and other drugs dispersed in ethyl cellulose PEG films [proceedings]. Donbrow M; Samoelov Y J Pharm Pharmacol; 1976 Dec; 28 Suppl():23P. PubMed ID: 12297 [No Abstract] [Full Text] [Related]
14. [Cellulose acetate phthalate coating of tablets disintegrating at a predetermined intestinal position]. Dragsted L; Boesen E; Wielandt TO; Krag E Ugeskr Laeger; 1979 May; 141(20):1328-30. PubMed ID: 452142 [No Abstract] [Full Text] [Related]
15. Application of hydroxypropyl cellulose to peroral controlled release dosage forms. Machida Y; Nagai T Chem Pharm Bull (Tokyo); 1978 Jun; 26(6):1652-8. PubMed ID: 699193 [No Abstract] [Full Text] [Related]
16. [Injection molding technic for the production of oral retard preparations. 2. Structure of the matrix]. Hüttenrauch R; Schmeiss U Pharmazie; 1975 Apr; 30(4):229-33. PubMed ID: 1153488 [No Abstract] [Full Text] [Related]
17. POLYMERIC PHARMACEUTICAL COATING MATERIALS. I. PREPARATION AND PROPERTIES. LAPPAS LC; MCKEEHAN W J Pharm Sci; 1965 Feb; 54():176-81. PubMed ID: 14293799 [No Abstract] [Full Text] [Related]
18. Application of Pisklak DM; Zielińska-Pisklak M; Szeleszczuk Ł Int J Pharm; 2016 Nov; 513(1-2):538-542. PubMed ID: 27667758 [TBL] [Abstract][Full Text] [Related]
19. Sustained-release dosage forms containing chlorpheniramine maleate with water-insoluble glucan. Masumoto K; Matsumoto K; Yoshida A; Hayashi S; Nambu N; Nagai T Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1055-62. PubMed ID: 6744480 [No Abstract] [Full Text] [Related]
20. Some aspects of controlled release dosage forms. Rachev D; Lambov N; Minkov E Pharmazie; 1989 Mar; 44(3):186-9. PubMed ID: 2664820 [No Abstract] [Full Text] [Related] [Next] [New Search]